Literature DB >> 8201956

Liver regrowth and apolipoprotein B secretion by rat hepatocytes following partial hepatectomy.

J D Sparks1, J P Corsetti, C E Sparks.   

Abstract

Apolipoprotein (apo) B is an essential component for the assembly and secretion of lipoproteins. The current report examines apo B production using primary cultures of hepatocytes derived from rats 3 to 21 days after partial hepatectomy (PH) to determine the effects of liver regrowth on apo B. Studies indicate that hepatocytes stimulated by PH have a two-thirds reduction in net apo B production 3 to 7 days after surgery, which coincides with the period of maximum rate of liver regrowth. Both higher (apo BH)- and lower-molecular-weight (apo BL) apo B are synthesized and secreted after PH, indicating the presence of edited apo B mRNA in hepatocytes. Hepatocytes derived from PH rats are more sensitive to insulin inhibition of apo B secretion compared with controls, suggesting an enhanced effect of insulin on newly replicated hepatocytes. Epidermal growth factor (EGF), a key regulator of liver regrowth following PH, potentiates the inhibitory action of insulin on apo B secretion in control hepatocytes and those derived from rats 2 to 3 weeks after PH. However, the potentiating effect of EGF on insulin inhibition of apo B is not discernible in hepatocytes 3 to 7 days after PH. The short-term in vitro hormonal effects occurring even with decreased apo B production suggest that this pathway remains available following PH to balance lipoprotein secretion with lipid and energy requirements necessary for liver regeneration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8201956     DOI: 10.1016/0026-0495(94)90115-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Acute suppression of apo B secretion by insulin occurs independently of MTP.

Authors:  Janet D Sparks; Jeffrey M Chamberlain; Colleen O'Dell; Irani Khatun; M Mahmood Hussain; Charles E Sparks
Journal:  Biochem Biophys Res Commun       Date:  2011-02-18       Impact factor: 3.575

2.  Interleukin-6 mediates hepatic hypersecretion of apolipoprotein B.

Authors:  Janet D Sparks; Joanne Cianci; Jenny Jokinen; Li Sheng Chen; Charles E Sparks
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-22       Impact factor: 4.052

3.  Insulin dependent apolipoprotein B degradation and phosphatidylinositide 3-kinase activation with microsomal translocation are restored in McArdle RH7777 cells following serum deprivation.

Authors:  Janet D Sparks; Amy L Magra; Jeffrey M Chamberlain; Colleen O'Dell; Charles E Sparks
Journal:  Biochem Biophys Res Commun       Date:  2015-11-23       Impact factor: 3.575

4.  The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.

Authors:  Nabil G Seidah; Suzanne Benjannet; Louise Wickham; Jadwiga Marcinkiewicz; Stephanie Belanger Jasmin; Stefano Stifani; Ajoy Basak; Annik Prat; Michel Chretien
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

5.  Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes.

Authors:  J D Sparks; T L Phung; M Bolognino; C E Sparks
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.